Sponsor:
Children's National Research Institute
Code:
NCT05528939
Conditions
Pediatric Cancer
Pediatric ALL
Pediatric Brain Tumor
Attention Difficulties
Cognitive Deficit in Attention
Eligibility Criteria
Sex: All
Age: 8 - 16
Healthy Volunteers: Not accepted
Interventions
EndeavorRx
Control video game
Brief summary:
Conditions
Pediatric Cancer
Pediatric ALL
Pediatric Brain Tumor
Attention Difficulties
Cognitive Deficit in Attention
Study ID
NCT05528939
Start date
Jun 14, 2023
Status verified date
Jan, 2025
Completion date
Aug 31, 2025
Anticipated
Primary completion date
Aug 31, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 8 - 16
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: EndeavorRx
active comparator: Control
Interventions
EndeavorRx
Control video game
Primary outcome measure
Central contacts
Locations
Children's National Hospital
Recruiting
Washington, District of Columbia, United States, 20010
Contacts
Sponsor
Children's National Research Institute
Last update posted
Jan 10, 2025
Last verified
Jan, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Children's National Research Institute on 2025-01-10.